In a patient with fever, a new heart murmur and risk factors (intravenous drug use, prosthetic heart valve, or prior cardiac disease), what do Janeway lesions, Osler nodes, and Roth spots signify and what are the recommended diagnostic steps and initial management for infective endocarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Janeway Lesions, Osler Nodes, and Roth Spots in Infective Endocarditis

What These Signs Mean

Janeway lesions, Osler nodes, and Roth spots are peripheral stigmata of infective endocarditis (IE) that should immediately trigger suspicion for this diagnosis, particularly when accompanied by fever and a new or changing heart murmur. 1

These three findings represent distinct pathophysiologic processes in IE:

  • Janeway lesions are painless, erythematous macules typically found on palms and soles, representing septic emboli and classified as vascular phenomena in the modified Duke criteria 2, 3
  • Osler nodes are painful, tender, purple nodular lesions usually on fingertips and toes, representing immunologic phenomena 2, 4, 3
  • Roth spots are retinal hemorrhages with pale centers, also classified as immunologic phenomena 2, 5

All three are minor criteria in the modified Duke diagnostic criteria for IE 2. However, their presence in contemporary practice is increasingly uncommon, as patients typically present earlier in the disease course 2, 6. When present, these skin manifestations may indicate a more complicated course with higher rates of complications and worse prognosis 7.

Immediate Diagnostic Steps

Blood Cultures (Most Critical First Step)

Obtain at least 3 sets of blood cultures from separate venipuncture sites BEFORE initiating any antimicrobial therapy. 2, 1, 4

  • Draw blood cultures more than 12 hours apart if possible, or ensure first and last samples are drawn at least 1 hour apart 2
  • This is a Class I recommendation with Level C evidence 2
  • Critical pitfall to avoid: Starting antibiotics before obtaining adequate blood cultures can render cultures negative and obscure the diagnosis 2, 5

Echocardiography (Definitive Imaging)

Perform transthoracic echocardiography (TTE) immediately as first-line imaging. 2, 1

  • TTE detects vegetations in 60-75% of IE cases 2, 5
  • If TTE is negative but clinical suspicion remains high, proceed immediately to transesophageal echocardiography (TEE), which has >95% sensitivity for detecting vegetations 2, 5
  • TEE is particularly recommended for patients with prosthetic valves, prior IE, or when complications such as paravalvular abscess are suspected 2
  • Repeat echocardiography within 7-10 days if initial examination is negative but clinical suspicion persists 2

Additional Laboratory Evaluation

Look for supportive laboratory findings that strengthen the diagnosis:

  • Elevated inflammatory markers (C-reactive protein, erythrocyte sedimentation rate) 2
  • Anemia, leukocytosis with left shift 8
  • Microscopic hematuria suggesting glomerulonephritis 2, 8

Modified Duke Criteria Application

The diagnosis requires either:

Definite IE: Two major criteria, OR one major plus three minor criteria, OR five minor criteria 2

Major criteria include:

  • Positive blood cultures with typical IE organisms (viridans streptococci, S. bovis, HACEK group, S. aureus, community-acquired enterococci) from 2 separate cultures 2
  • Persistently positive blood cultures (≥2 positive cultures drawn >12 hours apart, or all of 3 or majority of ≥4 cultures with first and last drawn ≥1 hour apart) 2
  • Echocardiographic evidence of endocardial involvement (vegetation, abscess, new prosthetic valve dehiscence) 2
  • New valvular regurgitation 2

Minor criteria include:

  • Predisposing heart condition or IV drug use 2
  • Fever >38°C 2
  • Vascular phenomena: major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, and Janeway lesions 2
  • Immunologic phenomena: glomerulonephritis, Osler nodes, Roth spots, and rheumatoid factor 2

Initial Management

Antimicrobial Therapy

After obtaining blood cultures, initiate empiric antimicrobial therapy immediately if clinical suspicion is high. 1, 4

  • The most common causative organisms are streptococci and staphylococci (80% of cases) 2
  • S. aureus causes 80% of tricuspid valve infections, particularly in IV drug users 2
  • Tailor therapy once blood culture results and sensitivities are available 1
  • Typical treatment duration is 4-6 weeks depending on organism and complications 1

Multidisciplinary Team Involvement

Immediately involve cardiology and infectious disease specialists in all suspected IE cases. 2, 1, 5

For complicated IE, transfer to a reference center with an "Endocarditis Team" including:

  • Infectious disease specialist 2, 1, 4
  • Cardiologist 2, 1
  • Cardiac surgeon 2, 1
  • Microbiologist 2
  • Imaging specialists 2

Surgical Consultation

Obtain early surgical consultation for all complicated IE cases. 1, 4

Indications for urgent surgical evaluation include:

  • Heart failure due to valvular destruction 1, 4
  • Uncontrolled infection despite appropriate antibiotics 1, 4
  • Prevention of embolic events (particularly with large vegetations >10mm) 1, 4
  • Paravalvular abscess or valve ring involvement 5
  • Persistent bacteremia despite adequate therapy 4

High-Risk Populations Requiring Heightened Suspicion

Be particularly vigilant for IE in patients with:

  • IV drug use (past or current) - this is the single most important risk factor to identify; fever in an IV drug user should immediately trigger IE workup 5, 6
  • Prosthetic heart valves 2, 1
  • Prior history of IE (the most common risk factor overall) 6
  • Congenital heart disease 2, 1
  • Recent dental procedures without prophylaxis 5
  • Intracardiac devices (pacemakers, defibrillators) 2
  • Immunocompromised states (HIV, diabetes, malignancy) 6

Critical Pitfalls to Avoid

  • Never start antibiotics before obtaining adequate blood cultures - this is the most common error that compromises diagnosis 2, 4, 5
  • Do not dismiss IE based on absence of classic peripheral stigmata - Janeway lesions, Osler nodes, and Roth spots are uncommon in contemporary practice 2, 6
  • Do not rely solely on TTE - proceed to TEE when clinical suspicion is high despite negative TTE 2
  • Do not delay surgical consultation - early involvement improves outcomes in complicated cases 1, 4
  • Do not manage complicated IE at non-reference centers - transfer to specialized "Endocarditis Team" facilities 2, 1, 4

References

Guideline

Diagnosis and Management of Infective Endocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dermatologic manifestations of infective endocarditis.

Anais brasileiros de dermatologia, 2016

Guideline

Management and Treatment of Osler Nodes in Infective Endocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clinical Presentation of Infective Endocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Infectious endocarditis: An update for emergency clinicians.

The American journal of emergency medicine, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.